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Abstract
Background:
The pH of commercially available local anesthetics (LAs) is purposefully low (pH 3–4). Decreasing the pH
extends the shelf life of the solution and prevents its early oxidation. However, a low pH may produce a
burning sensation on the injection site, a slower onset of anesthesia, and a decrease in its clinical efficacy.
Buffering of local anesthetics (alkalinization) by adding sodium bicarbonate has been suggested to achieve
better pain control, reduce the pain of injection and produce a faster onset of local anesthetics. The aim of this
review is to utilize a systematic review to collate evidence on the use of buffering agents with local anesthetics
and its effect on causing profound pulpal anesthesia in patients requiring dental therapy and its side effects.
Methods:
Electronic searches were conducted in MEDLINE, Scopus, Cochrane Library, and ClinicalTrials.gov, World
Health Organization (WHO) International Trials Registry Platform, OpenGrey & Google Scholar beta. Hand
searching of two books “Handbook of Local Anesthesia” & “Successful Local Anesthesia for Restorative
Dentistry and Endodontics” was conducted. Also, the reference lists of all included and excluded studies were
checked to identify any further trials. Weighted anesthesia success rates and 95% confidence intervals (CIs)
were estimated and compared by using a random-effects model.
Results:
14,011 studies were initially identified from the search; 5 double-blind, randomized clinical trials met the
inclusion criteria. For combined studies, buffered local anesthetics were more likely than non-buffered
solutions to achieve successful anesthesia (odds ratio [OR], 2.29; 95% confidence interval [CI], 1.11–4.71; P
= 0.0232; I2 = 66%).
Conclusion:
This systematic review of double-blind, randomized clinical trials comparing the use of buffered and non-
buffered local anesthetics in patients requiring dental therapy provides level ‘A’ evidence that is based on the
criteria given by the Strength of Recommendation Taxonomy (SORT). In conclusion, the present meta-
analysis showed that in patients receiving dental therapy, buffered local anesthetics are more effective than
non-buffered solutions when used for mandibular or maxillary anesthesia. Buffering local anesthetics has 2.29
times greater likelihood of achieving successful anesthesia.
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Abstract  
Background: The pH of commercially available local anesthetics (LAs) is purposefully low (pH 
3–4). Decreasing the pH extends the shelf life of the solution and prevents its early 
oxidation. However, a low pH may produce a burning sensation on the injection site, a 
slower onset of anesthesia, and a decrease in its clinical efficacy. Buffering of local 
anesthetics (alkalinization) by adding sodium bicarbonate has been suggested to achieve 
better pain control, reduce the pain of injection and produce a faster onset of local 
anesthetics. The aim of this review is to utilize a systematic review to collate evidence on 
the use of buffering agents with local anesthetics and its effect on causing profound pulpal 
anesthesia in patients requiring dental therapy and its side effects. Methods: Electronic 
searches were conducted in MEDLINE, Scopus, Cochrane Library, and ClinicalTrials.gov, 
World Health Organization (WHO) International Trials Registry Platform, OpenGrey & 
Google Scholar beta. Hand searching of two books “Handbook of Local Anesthesia” & 
“Successful Local Anesthesia for Restorative Dentistry and Endodontics” was conducted. 
Also, the reference lists of all included and excluded studies were checked to identify any 
further trials. Weighted anesthesia success rates and 95% confidence intervals (CIs) were 
estimated and compared by using a random-effects model. Results: 14,011 studies were 
initially identified from the search; 5 double-blind, randomized clinical trials met the 
inclusion criteria. For combined studies, buffered local anesthetics were more likely than 
non-buffered solutions to achieve successful anesthesia (odds ratio [OR], 2.29; 95% 
confidence interval [CI], 1.11–4.71; P = 0.0232; I2 = 66%). Conclusion: This systematic review 
of double-blind, randomized clinical trials comparing the use of buffered and non-buffered 
local anesthetics in patients requiring dental therapy provides level ‘A’ evidence that is 
based on the criteria given by the Strength of Recommendation Taxonomy (SORT). In 
conclusion, the present meta-analysis showed that in patients receiving dental therapy, 
buffered local anesthetics are more effective than non-buffered solutions when used for 
mandibular or maxillary anesthesia. Buffering local anesthetics has 2.29 times greater 
likelihood of achieving successful anesthesia.  
Keywords: Buffering, Buffered, Sodium Bicarbonate, Alkalinization, Adjusting pH, Local 
anesthesia, Dentistry, Systematic review.  
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B A C K G R O U N D: Local anesthetics (LAs) form the backbone of pain control techniques in 
dentistry. They are the most utilized drugs in dentistry. The site of action of local anesthetics 
is believed to be the nerve membrane. In nerve cells, action potentials are created by the 
influx of sodium ions from the surrounding tissues. These action potentials result in the 
conduction of nerve impulses that produce sensations, including pain. Local anesthetics 
prevent the conduction of impulses by decreasing the permeability of nerve membranes to 
sodium ions. By impeding the influx of sodium ions into the neuron, local anesthetics block 
the conduction of impulses, prevent excitation along a neural pathway, and give rise to 
anesthesia (Malamed, 2013).  
Two ionic forms of the local anesthesia exist in equilibrium within an anesthetic cartridge: 
RN (the uncharged, deionized, ‘active’ free base form of the drug which is lipid soluble) and 
RNH+ (the ‘charged’ or ionized cationic form, which is not lipid soluble); only the lipid 
soluble de-ionized form can cross the nerve membrane. Once within the nerve, the RN picks 
up a H+ with the resultant RNH+ entering a Na+ channel to block nerve conduction. Only 
after the body buffers the pH of the anesthetic solution closer toward the physiologic range 
(7.35 – 7.45) does the anesthetic begin to take effect. The time that this transformation 
requires is a key factor in anesthetic latency (Malamed, 2013). Inflammation and infection 
represent an additional obstacle in anesthetic performance. Lower tissue pH at the site of 
inflammation/infection makes it extremely difficult for the typical local anesthetic injection 
to provide adequate pulpal anesthesia. Inflamed/infected tissue is more acidic, which makes 
it more difficult for the RN conversion to occur (Hargreaves & Keiser, 2002). 
 
Description of the intervention 
The pH of most local anesthetics is purposefully low (pH 3–4), because the charged acid 
form of the molecule is more stable and more water soluble, and thus gives a longer shelf 
life (Malamed, 2013). The low pH of local anesthetics may contribute to pain during the 
actual administration (injection) of the local anesthetic solution; a slower than desired onset 
of profound (pulpal) anesthesia; and less than optimal effectiveness when seeking to 
anaesthetize inflamed/infected teeth (Malamed, 2013; Hargreaves & Keiser, 2002). 
Buffering of local anesthetics (alkalinization) has been suggested to achieve pain control 
(Davies, 2003) buffering will increase the dissociation rate of the local anesthetic molecule 
and thus increase the uncharged base form that crosses the nerve membrane to the intra-
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neuronal site where it exerts its action (Gosteli et al., 1995). 
The most common method for buffering of local anesthetics is with the addition of sodium 
bicarbonate. It is an alkalinizing agent, which is most commonly used for the treatment of 
metabolic acidosis. 
 
How the intervention might work 
The addition of sodium bicarbonate to local anesthetics not only will increase the pH of the 
solution, but will also result in the production of carbon dioxide and water (Ackerman et al., 
1992). Several authors have reported on the effect of carbon dioxide on local anesthetics 
and anesthesia. Condouris & Shakalis (1964) in an isolated rat sciatic nerve model reported 
that carbon dioxide potentiated the action of local anesthetics by showing that in the 
presence of carbon dioxide; nerve conduction blockade was significantly greater than in its 
absence. Bromage et al. (1967) suggested that carbon dioxide acts by increasing the flow of 
local anesthetic into the nerve and demonstrated that the addition of carbon dioxide to 
lignocaine shortened the time to onset and spread of analgesia by 20% to 30% in epidural 
anesthesia. Bokesch et al. (1987) also studied the effects of carbon dioxide and concluded 
that its role in potentiating local anesthesia was related to either a direct effect on the nerve 
membrane or by indirect action on intracellular pH.  
Catchlove (1973) concluded that carbon dioxide potentiates local anesthesia by three 
mechanisms:  
1. A direct depressant effect of carbon dioxide on the axon. 
2. Concentrating the local anesthetic inside the nerve trunk (ion trapping). 
3. Converting the local anesthetic to the active cationic form within the nerve axoplasm by 
lowering its internal pH. 
 
Why it is important to do this review 
Buffering of local anesthetics is well known and accepted in medicine and many studies 
have shown that it reduces pain of injection (Davies, 2003; Burns et al., 2006) and increases 
clinical efficacy of local anesthetics (Davies, 2003; Curatolo et al., 1998). Davies (2003) 
reviewed the literature on buffering local anesthetics to decrease the pain of injection and 
found that buffering local anesthetics with sodium bicarbonate significantly reduced 
injection pain. Galindo (1983) used pH-adjusted local anesthetics solutions (pH 7.4) in 
epidurals, peripheral nerve blocks, and regional anesthesia. He found that higher pH 
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solutions established anesthesia of better quality. The question in dentistry has been: “do 
buffered local anesthetics provide an advantage over standard solutions in patients 
requiring dental therapy as well?” 
 
O B J E C T I V E S: The purpose of this study was to conduct a systematic review that 
address the following population, intervention, comparison, outcome (PICO) question: In 
adults requiring dental therapy, what’s the comparative efficacy of buffered local 
anesthetics compared to non-buffered (standard) solutions in achieving anesthetic success 
and not increasing incidence of side effects? 
 
M E T H O D S 
Criteria for considering studies for this review  
Types of studies 
All randomized double-blinded clinical trials (RCTs) on anesthetic success of buffered local 
anesthetics compared with non-buffered (standard) solutions; only parallel group RCTs are 
included. 
 
Types of participants 
Adults of 18 years and older of either sex, all ethnicities, settings, or socio-economic group, 
absence of a significant medical condition, and in need of dental therapy were the 
participants included in this review. 
 
Types of interventions 
The intervention compared was the use of either buffered or non-buffered (standard) local 
anesthetics using different delivery routes in patients requiring different dental treatments. 
 
Types of outcome measures 
Primary outcome 
The primary outcome successful anesthesia that was assessed based on each study’s criteria 
(for example, by using a Verbal Analog Scale, Visual Analogue Scale (VAS), and cold test or 
electric pulp tests and/or by initiating treatment procedures). 
 
Secondary outcome 
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Adverse events 
The number of patients presenting with adverse events, such as well-established local 
anesthetic toxic-reactions, skin rash, allergic reactions, or others was extracted. 
 
Exclusion Criteria: 
- Insufficient information about the definition of anesthetic success. 
- Studies that don’t evaluate anesthetic success. 
- Dichotomous data for anesthesia outcome were unavailable. 
- Crossover design randomized clinical trials (RCTs) done in healthy asymptomatic 
subjects. 
- Patient population requiring treatment other than dental therapy. 
 
Search methods for identification of studies 
For the identification of studies included or considered for this review, a detailed search 
strategy was developed a for each database searched. These were based on the search 
strategy developed for MEDLINE but revised appropriately for each database to take 
account of differences in controlled vocabulary and syntax rules. 
The search strategy combined the subject search with the Cochrane Highly Sensitive Search 
Strategy for identifying reports of RCTs (2008 revision), as published in Box 6.4.f in the 
Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The subject 
search used a combination of controlled vocabulary and free text-terms based on the search 
strategy for searching MEDLINE. 
 
Electronic searches 
The following databases were searched: 
• Cochrane Central Register of Controlled Trials (CENTRAL);  
• MEDLINE via PubMed (1946 to 1 November 2016); 
• Scopus.  
See Appendix 1 for details of all search strategies used. All databases were searched from 
their inception to November 2016 and no restrictions on language of publication were 
applied in the electronic searches. 
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Searching other resources 
The following trials registers were searched for ongoing studies: 
• World Health Organization (WHO) International Trials Registry Platform (to 1 November 
2016) (www.who.int/ictrp/en/); 
• U.S. National Institutes of Health Trials Registry (ClinicalTrials.gov) (to 1 November 2016). 
Grey literature was searched using the following resources: 
• OpenGrey (to 1 November 2016); 
• Google Scholar beta (to 1 November 2016). 
Two books were hand searched: 
• Handbook of Local Anesthesia, 6th edition;  
• Successful Local Anesthesia for Restorative Dentistry and Endodontics. 
- Also, the reference lists of all included and excluded studies were checked to identify any 
further trials. 
 
Selection of studies 
The abstracts of studies resulting from the searches were assessed. Full text copies of all 
relevant and potentially relevant studies were obtained, those appearing to meet the 
inclusion criteria, or for which there were insufficient data in the title and abstract to make a 
clear decision were reviewed. After assessment, any duplicate publications or remaining 
studies that did not match the inclusion criteria were excluded from further review and the 
reasons for their exclusion noted in the ’Characteristics of excluded studies’ table. The 
screening and selection process is outlined in a PRISMA flow chart ‘see Figure 1’ 
 
Data extraction and management 
Study details were entered into the Characteristics of included studies table (Table 2). A 
data extraction sheet based on the Cochrane Consumers and Communication Review 
Groups data extraction template (Cochrane Consumers and Communication Review Group 
(2015). Data extraction template. Available at: http://cccrg.cochrane.org/author-resources) 
was used to record data extracted from the full-text article. The data extracted from each 
included article was the following: 
1. General information (author, year, title, journal, dental procedure) 
2. Trial characteristics (sample size, type of study design, method of randomization, 
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allocation concealment, blinding) 
3. Type of intervention (buffering agent used, anesthetics used, injection route/delivery 
method, pH of the solution) 
4. Characteristics of trial participants (number of patients for each intervention, mean age, 
gender distribution) 
5. Type of outcome measure (method to assess anesthesia success, definition of success). 
6. Miscellaneous (conclusion and source of funding/conflict of interest) 
 
Assessment of risk of bias in included studies 
The selected trials were graded following the domain-based evaluation described in Chapter 
8 of the Cochrane Handbook (http://handbook.cochrane.org).  
The following domains were assessed as ’low risk’ of bias, ’unclear’ (i.e. uncertain risk of 
bias) or ’high risk’ of bias. 
1. Sequence generation 
2. Allocation concealment 
3. Blinding (of participants, personnel and outcome assessors, data analysts) 
4. Incomplete outcome data 
5. Selective outcome reporting 
6. Other potential sources of bias 
These assessments were reported in the “Risk of bias” tables for each individual study. 
In addition, the overall risk of bias in each included study was categorized according to the 
following: 
• Low risk of bias (plausible bias unlikely to seriously alter the results) if all criteria were 
met. 
• Un-clear risk of bias (plausible bias that raises some doubt about the results) if one or 
more criteria were assessed as unclear. 
• High risk of bias (plausible bias that seriously weakens confidence in the results) if one or 
more criteria were not met. 
 
Measures of treatment effect 
For dichotomous outcomes, the estimate of effect of the intervention was expressed as 
odds ratios (OR) together with 95% confidence intervals (CI). 
 
  - 9 - 
 
Dealing with missing data 
The original investigators were contacted in cases of missing data. 
 
Assessment of heterogeneity 
Clinical heterogeneity was assessed by examining the characteristics of the studies, the 
similarity between the types of participants, the interventions and the outcomes as 
specified in the criteria for included studies. Statistical values of 30% to 60% indicate 
moderate to high heterogeneity, 50% to 90% substantial heterogeneity and 75% to 100% 
studies has considerable heterogeneity (Higgins & Green, 2011). 
 
Assessment of reporting biases 
Assessment of reporting bias through funnel plots and formal testing (Egger, 1997) were 
planned if data from 10 or more studies were available. 
 
R E S U L T S 
Description of studies 
See Characteristics of included studies (Table 2) and Characteristics of excluded studies 
(Table 3). 
 
Results of the search 
The electronic searches retrieved 14,011 references to studies. After examination of the 
titles and abstracts of these references, all of those that did not match the inclusion criteria 
and were clearly ineligible were eliminated. Full text copies of the remaining studies were 
obtained and subjected to further evaluation. Searching the grey literature through Google 
Scholar Beta and OpenGrey, two eligible studies could be retrieved. 
The searches of the WHO International Clinical Trials Registry Platform and the 
ClinicalTrials.gov databases did not identify any ongoing trials. 
Hand searching of two books revealed that no additional studies could be retrieved over 
and above those that had already been identified in the electronic search. For further details 
see ’Study Flow’ diagram (Figure 1). 
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Records identified through 
database searching                 
CENTRAL (n= 130)                                       
PubMed (n= 154)                    
Scopus (n=10,682) 
Additional records identified 
through other sources 
ClinicalTrials.gov (n= 23) 
Google Scholar (n= 3,210) 
 
Records after duplicates 
removed (n= 14,011) 
removed (188) 
Records screened                
(n = 14,011) 
Records excluded                
(n = 13,982) 
 
Full-text articles assessed 
for eligibility 
(n= 29) 
Full-text articles excluded, 
with reasons 
(n= 24) 
Studies included in 
qualitative synthesis (n= 5) 
 
Studies included in 
quantitative synthesis 
(meta-analysis) (n= 5) 
Figure 1: Study flow chart 
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Included studies 
Five double-blind, randomized controlled trials (RCTs) satisfied the inclusion criteria (Al-
Sultan et al., 2006; Gupta et al., 2014; Saatchi et al., 2015; Saatchi et al., 2016; Schellenberg 
et al., 2015). See Characteristics of included studies table for further details (Table 2). 
 
Characteristics of the trial settings, investigators and methods 
All the studies were parallel group double-blind, randomized controlled trials which had 
been conducted in Iraq, India, Iran and the USA. A university or dental school was the 
setting in all the studies (Al-Sultan et al., 2006; Saatchi et al., 2015; Saatchi et al., 2016; 
Schellenberg et al., 2015), except for one study, which was conducted in a private practice 
(Gupta et al., 2014). 
 
Characteristics of the participants 
A total of 560 participants were investigated and provided 669 teeth in the five studies. The 
age of the participants ranged from 18 to 64 years and included both genders. Anterior and 
posterior teeth, both single and multi-rooted, were investigated. In three of the included 
studies, the participants had a clinical diagnosis of symptomatic irreversible pulpitis 
requiring root canal treatment (Saatchi et al., 2015; Saatchi et al., 2016; Schellenberg et al., 
2015). In another study (Al-Sultan et al., 2006) participants had either failed conventional 
root canal treatment with large periapical radiolucency or failed endodontic surgery 
requiring periapical surgery/re-surgery, whereas in (Gupta et al., 2014) participants had 
periapical infection and teeth were indicated for extraction.  
 
Characteristics of the interventions 
There was considerable methodological heterogeneity between studies that included 
differences in anatomic location of teeth being anesthetized (maxilla or mandible, anterior 
or posterior), tooth type (molars, premolars, or anterior teeth), volume of anesthetic 
solution administered during the intervention (0.3 mL, 1.62 mL, 1.8 mL, 2.8 mL, 3.7 mL), 
volume of buffering solution administered (0.1 mL, 0.18 mL, 0.7 mL, 1.3 mL), concentration 
of epinephrine (1: 80,000, 1: 100,000). Anesthetic solutions were delivered via inferior 
alveolar nerve block (IANB), maxillary buccal infiltration (MaxBI), and supplemental 
mandibular buccal infiltration (SupManBI). 
All studies used sodium bicarbonate as a buffering agent. 
  - 12 - 
- 1.8 ml of 2% Lidocaine with 1: 80,000 epinephrine (pH 3.5) vs. 1.7 ml 2% Lidocaine 
with 1: 80,000 epinephrine + 0.1 ml of 8.4% sodium bicarbonate (pH 7.2) (each 
patient was given 3 carpules, maxillary buccal infiltration) (Al-Sultan et al., 2006). 
- 3.7 ml of 2% Lidocaine with 1: 80,000 epinephrine (pH 3.91) vs. 3.7 ml 2% Lidocaine 
with 1: 80,000 epinephrine + 1.3 ml of 7.4% sodium bicarbonate (pH 7.51) (Maxillary 
buccal infiltration) (Gupta et al., 2014). 
- 1.62 ml of 2% Lidocaine with 1: 80,000 epinephrine + 0.18 ml of sterile saline vs. 1.62 
ml of 2% Lidocaine with 1: 80,000 epinephrine + 0.18 ml of 8.4% sodium bicarbonate 
(each patient was given 2 carpules, IANB) (Saatchi et al., 2015). 
- 0.3 ml of 2% Lidocaine with 1: 80,000 epinephrine + 0.7 ml of sterile saline vs. 0.3 ml 
of 2% Lidocaine with 1: 80,000 epinephrine + 0.7 ml of 8.4% sodium bicarbonate 
(Mandibular buccal infiltration) (Saatchi et al., 2016). 
- 2.8 ml of 4% Lidocaine with 1: 100,000 epinephrine (pH 4.51) vs. 2.62 ml 4% Lidocaine 
with 1: 100,000 epinephrine + 0.18 ml of 8.4% sodium bicarbonate (pH 7.05) (each 
patient was given 2 carpules, IANB) (Schellenberg et al., 2015). 
 
Characteristics of the outcomes measures 
All studies evaluated anesthetic success of buffered local anesthetics and controls, which is 
the primary outcome of this review. In three of the included studies (Saatchi et al., 2015; 
Saatchi et al., 2016; Schellenberg et al., 2015) anesthetic success was defined as no or mild 
pain (≤ 54 mm on a 170-mm visual analog scale) based on Heft-Parker Visual analogue scale 
recordings upon access cavity preparation or initial instrumentation. In study by (Al-Sultan 
et al., 2006) pain grade during periapical surgery was recorded by the operator and 
represented the patients’ pain response during the period of the operation according to the 
Dobb and Devier System where no or mild pain tolerated by the patient is considered as 
success or if the patient experienced severe pain that was intolerable and additional 
anesthesia was administered that was considered as failure. In Gupta et al., (2014) no pain 
or mild pain tolerable by patient during extraction based on Visual analogue scale (VAS) was 
considered as success. 
 
Excluded studies 
We excluded the majority of references, as they did not report relevant outcomes, didn’t 
present data as dichotomous outcome, or had other characteristics that did not satisfy the 
inclusion criteria (see Characteristics of excluded studies, Table 3). 
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Risk of bias in included studies 
*Allocation 
-Randomization 
In four studies the random sequence generation was unclear (Al-Sultan et al., 2006; Gupta el 
at., 2014; Saatchi et al., 2015; Saatchi et al., 2016), only one study had an adequate 
randomization (Schellenberg et al., 2015). 
 
-Allocation concealment 
One study had an unclear allocation concealment (Gupta et al., 2014) but all other studies 
had adequate allocation concealment (Al-Sultan et al., 2006; Saatchi et al., 2015; Saatchi et 
al., 2016; Schellenberg et al., 2015).  
 
*Blinding 
All included studies were double blinded, and all of them had an adequate blinding of 
participants and personnel and of outcome assessment as well. 
 
*Incomplete outcome data 
All studies had complete outcome data. 
 
*Selective outcome reporting 
There was no selective reporting of outcomes in any of the studies. 
 
*Other potential sources of bias 
There were no other potential sources of bias in any of the studies. 
 
*Overall risk of bias 
Four studies are judged to have overall unclear risk of bias (Al-sultan et al., 2006; Gupta et 
al., 2014; Saatchi et al., 2015; Saatchi et al., 2016), only one study (Schellenberg et al., 2015) 
had an overall low risk of bias. 
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Table 1: Risk of bias assessment: 
 
 
Study Selection: 
Random 
sequence 
generation 
Selection: 
Allocation 
concealm
ent 
Performance: 
Blinding of 
participants 
and 
personnel 
Detection: 
Blinding of 
outcome 
assessment 
Attrition: 
Incomplet
e outcome 
data 
Reporting: 
Selective 
reporting 
Other 
biases 
Al-Sultan et al. 
2006 
Unclear Low risk Low risk Low risk Low risk Low risk Low risk 
Gupta et al. 2014 Unclear Unclear  
 
Low risk Low risk Low risk Low risk Low risk 
Saatchi et al. 
2015 
Unclear  
 
Low risk Low risk Low risk Low risk Low risk Low risk 
Saatchi et al. 
2016 
Unclear  
 
Low risk Low risk Low risk Low risk Low risk Low risk 
Schellenberg et 
al. 2015 
Low risk Low risk Low risk Low risk Low risk Low risk Low risk 
 
 Random 
sequence 
generation 
Allocation 
concealment 
Blinding of 
participants 
and 
personnel 
Blinding of 
outcome 
assessment 
Incomplete 
outcome 
data 
Selective 
reporting 
Other 
biases 
Al-Sultan et 
al. 2006 
? + + + + + + 
Gupta et al. 
2014 
? ? + + + + + 
Saatchi et al. 
2015 
? + + + + + + 
Saatchi et al. 
2016 
? + + + + + + 
Schellenberg 
et al. 2015 
+ + + + + + + 
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Figure 2: Forest plot of ORs of buffered local anesthetics vs. non-buffered form: showing 
buffered local anesthetics to have treatment effect 2.29 times greater than non-buffered 
form. 
 
Primary outcomes 
Successful anesthesia 
The primary outcome assessed was successful anesthesia that was based on each study’s 
criteria. Success was defined in 3 studies (Saatchi et al., 2015; Saatchi et al., 2016; 
Schellenberg et al., 2015) as no pain or mild/bearable pain/discomfort according to patient-
reported pain scores (eg. HP-VAS) during endodontic treatment access cavity preparation 
and instrumentation; one study defined successful anesthesia as no pain or mild/tolerable 
pain during procedure (Al-Sultan et al., 2006). In study by Gupta et al., (2014) no pain or 
mild pain tolerable by patient during extraction based on visual analogue scale (VAS) was 
considered as success. 
 
Secondary outcomes 
Adverse events 
Gupta et al., (2014) reported the absence of adverse events whereas the other studies made 
no mention. 
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Meta-analysis 
Success rates for buffered and non-buffered local anesthetics ranged from low of 32% and 
40%, respectively, to 92.5% and 80%, respectively (Table 2). For combined studies, buffered 
local anesthetics were more likely than non-buffered solutions to achieve successful 
anesthesia (odds ratio [OR], 2.29; 95% confidence interval [CI], 1.11-4.71; P = 0.0232; I2 = 
66%). 
As recommended by the Cochrane Handbook for Systematic Reviews of Interventions 
Version 5.1.0 (updated March 2011) section “10.4.3.1 Recommendations on testing for 
funnel plot asymmetry“ (http://handbook.cochrane.org), tests for funnel plot asymmetry 
should be used only when there are at least 10 studies included in the meta-analysis, 
because when there are fewer studies the power of the tests is too low to distinguish 
chance from real asymmetry. As in this review we have only 5 studies included in the final 
meta-analysis, publication bias won’t be assessed by tests due to lack of enough sample size 
and number of studies included to detect publication bias. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  - 17 - 
D I S C U S S I O N 
This systematic review of double-blind, randomized clinical trials (RCTs) comparing the use 
of buffered and non-buffered local anesthetics in patients requiring dental therapy provides 
level ‘A’ evidence that is based on the criteria given by the Strength of Recommendation 
Taxonomy (SORT). The main conclusion that can be drawn from this study is that there is a 
significant advantage to Increasing the pH (buffering) of local anesthetic solutions as it 
increases the quality of the anesthetic blockade. 
 
It should be mentioned that in this review crossover design randomized clinical trials (RCTs) 
done in healthy asymptomatic subjects were excluded. In such situations, once local 
anesthetic solution is injected into the tissues, the natural process of buffering should occur 
rapidly. The normal pH of tissues is 7.4. A drug with a lower pH (e.g. 3.5) that is injected into 
tissues will be buffered by the body, and the pH of the injected solution will be slowly 
increased toward pH of 7.4. As this process continues, the percentage of the base in the 
solution steadily increases which could readily penetrates the nerve providing the desired 
anesthetic effect. However, cases of inflammation/infection represent an additional 
obstacle in anesthetic performance. The lower pH at the site of inflammation/infection 
makes it extremely difficult for the typical local anesthetic injection to provide adequate 
pulpal anesthesia. Acidic pH of the tissue reduces the amount of the base form of local 
anesthetic to penetrate the nerve membrane. Consequently, there is less of the ionized 
form within the nerve to achieve anesthesia. Hence, in this systematic review only double-
blind randomized clinical trials (RCTs) were included where subjects require dental therapy 
for underlying inflammation/infection, instead of healthy subjects, to evaluate the effect of 
buffering local anesthetics in such challenging conditions. 
This systematic review included several studies not previously reviewed. Three of these 
studies evaluated mandibular posterior teeth (Saatchi et al., 2015; Saatchi et al., 2016; 
Schellenberg et al., 2015), and two evaluated maxillary anterior teeth (Al-Sultan et al., 2006; 
Gupta et al., 2014). In those two studies (Al-Sultan et al., 2006; Gupta et al., 2014) the 
success rate was generally higher than studies on mandibular posterior teeth included in 
this review, and that was not surprising as clinically, maxillary anesthesia is more easily 
obtained and successful than mandibular anesthesia (Kaufman et al., 1984). In maxillary 
anterior and posterior teeth, infiltration anesthesia results in a high incidence (90% - 95%) of 
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successful anesthesia. Whereas achieving successful anesthesia in mandibular teeth 
specially in cases of symptomatic irreversible pulpitis is challenging and more difficult 
(Fluery, 1990; Hargreaves et al., 2002; Quint, 1981). Reported clinical success of inferior 
alveolar block alone in cases of symptomatic irreversible pulpitis is between 19% to 56% 
which could explain lowered success rate in three studies (Saatchi et al., 2015; Saatchi et al., 
2016; Schellenberg et al., 2015) included in this review. 
One potential method to increase anesthetic success is to increase the injection volume of 
local anesthetic solution. In this review, different volumes and concentrations of local 
anesthetic solution were evaluated (Table 2). However, clinical studies showed that 
increasing the volume of 2% lidocaine (2 cartridges) does not increase the incidence of 
pulpal anesthesia of mandibular posterior teeth with the inferior alveolar nerve block 
(Nusstein et al., 2002; Vreeland et al., 1989; Yared et al., 1997).  
The addition of epinephrine to local anesthetic solutions facilitates vasoconstriction, slows 
systemic absorption, and increases the duration and depth of local anesthetics. In this 
review 4 of the 5 studies used 1:80,000 epinephrine (Al-Sultan et al., 2006; Gupta et al., 
2014; Saatchi et al., 2015; Saatchi et al., 2016) and one study used 4% lidocaine with 1: 
100,000 epinephrine (Schellenberg et al., 2015). Dagher et al. (1997) found no significant 
differences in degree of anesthesia obtained by using 2% lidocaine with 1: 50,000, 1: 80,000, 
or 1: 100,000 concentrations of epinephrine. it is reasonable to expect that these variations 
in local anesthetic “volume and concentration” and epinephrine concentration would not 
likely have a major impact on the outcomes evaluated in this review. 
In this review, two studies evaluated the effect of buffering local anesthetics in patients 
receiving inferior alveolar nerve block (IANB) and having symptomatic irreversible pulpitis 
(Saatchi et al., 2015; Schellenberg et al., 2015). Schellenberg et al., (2015) showed that 
increasing the pH of local anesthetic solutions didn’t improve anesthetic success of IANB in 
patients having symptomatic irreversible pulpitis. Their results showed that the original 
formulation of the 4% lidocaine with 1: 100,000 epinephrine provided 40% success, while 
administration of the buffered formula resulted in 32% success. Saatchi et al., (2015) found 
that using 3.24 mL buffered 2% lidocaine with 1: 80,000 epinephrine in patients with 
symptomatic irreversible pulpitis resulted in a success rate (none or mild pain during access 
or instrumentation) of 62% and the original formula resulted in success of 47.5%. The lower 
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success rate of buffered local anesthetic solution in the study by Schellenberg et al., (2015) 
may have been caused by population differences and lower actual amount of the injected 
lidocaine in the buffered formula group compared to the original one (14.4 mg lower). 
In the present review only 1 of the 5 studies reported the absence of adverse events (Gupta 
et al., 2014) whereas the other studies made no mention of it. It is important that future 
clinical studies incorporate the reporting of adverse events in their methodology.  
Buffering of lidocaine is most commonly performed by adding 1 ml of 8.4% sodium 
bicarbonate to 10 ml of local anesthetic. An 8.4% solution of sodium bicarbonate would 
contain 1 mEq each of sodium and bicarbonate ions per mL. The 10:1 local anesthetic to 
bicarbonate ratio has been shown to raise the pH to a more physiologic range (Richtsmeier 
& Hatcher, 1995). Buffering of local anesthetic solutions with sodium bicarbonate not only 
raises the pH of the solutions but also leads to production of carbon dioxide (CO2) and 
water as a byproduct. Catchlove, (1973) first demonstrated that CO2 in a lidocaine solution 
has an independent anesthetic effect and that both chemicals have similar effects on 
peripheral nerves. He suggested that in situations in which a solution contains both 
lidocaine and CO2, the CO2 may cause the more immediate form of analgesia because it 
diffuses rapidly through the nerve sheath and probably reaches the axon before the local 
anesthetic. While this initial effect may be beneficial, as a gas, however, buffered 
anesthetics in a glass carpule may be considered unstable. Without the timely injection of 
the buffered mixture, the unreleased gas may be further responsible for the recognized 
precipitate over time. Tissue damage from such an unstable mixture and precipitate could 
also be of clinical concern. No precipitation was reported in any of the studies included. All 
local anesthetics containing epinephrine are marketed at acidic pHs which provides 
chemical stability and longer shelf life. The sodium metabisulfite antioxidant which increases 
the shelf life of epinephrine further decreases the pH (Fyhr & Brodin, 1987). Furthermore, 
clinicians need to be aware that although the local anesthetic concentration in buffered 
solutions remains constant over time, epinephrine concentrations in buffered lidocaine 
solutions decrease substantially over 24 hours (Larson et al., 1991; Robinson et al., 2000). 
Therefore, production of prepared buffered solutions of local anesthetic in factories is not 
preferred. 
In 2010, the Food and Drug Administration approved the Onpharma® mixing system 
(Onpharma Inc., www.onpharma.com) for buffering of lidocaine. The mixing system consists 
of three parts: the Onpharma® mixing pen, the Onpharma® cartridge connector, and the 
Onset® Sodium Bicarbonate Injection, 8.4% USP Neutralizing Additive Solution. This system 
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provides a convenient chairside mixing and delivery of buffered lidocaine and is easy to use 
and simple to learn. However, it has some disadvantages, the price of the unit is $450.00 
with cartridge connectors $50.00 (box of 4) and sodium bicarbonate is $225.00 (box of 4 
ampules) which increases the cost of a dental treatment. The sodium bicarbonate needs to 
be replaced once per day with the connectors replaced for every patient. Furthermore, the 
time required for each patient is about 1 minute to set up the assembly and less than 15 
seconds to mix the solutions. Other than the expense and time required to mix solutions, 
this system is technique sensitive, an extra step is needed to mix the solutions and there are 
some concerns with infection control. Another alternative would be the preparation of 
double vials. The upper vial will have sodium bicarbonate as a dry substance and the lower 
vial the anesthetic solution so that the bicarbonate can be introduced into the local 
anesthetic solution at the time of injection. 
Clinicians should be mindful of the limitation that this systematic review focused on the 
quality of the anesthetic blockade and did not evaluate other factors as the pain on 
injection, the duration or the post-injection discomfort when interpreting the results of the 
review. Moreover, the underlying heterogeneity of the included studies presents 
limitations. Such heterogeneity includes geographic location, sample size, number and 
experience of operators, amount and concentration of sodium bicarbonate added, pH of the 
solution and tissue, the volume of local anesthetic, the concentration of epinephrine, 
reproducibility of injection route, and evaluation scale used to assess pain and definition of 
success (VAS, HP-VAS, access cavity, pain felt during the procedure). In an effort to allow for 
heterogeneity issues, the meta-analysis used a random-effects model of statistical analysis, 
as opposed to the fixed-effects model that is used in cases with no evidence of 
heterogeneity.  
 
To our best knowledge this systematic review is the first to evaluate the effect of buffering 
local anesthetic solutions on efficacy and success of local anesthesia in patients requiring 
dental therapy. Although the number of studies in this analysis was limited and 
heterogeneity existed, the results of this systematic review indicate that buffering of local 
anesthetics solutions admixture immediately prior to clinical use increase its efficacy 
without any side effects. 
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C O N C L U S I O N 
In conclusion, the present meta-analysis showed that in patients requiring dental therapy, 
buffered local anesthetics is more effective than non-buffered solutions when used for 
mandibular or maxillary anesthesia. Buffering local anesthetics has 2.29 times greater 
likelihood of achieving successful anesthesia. Also, further comparative studies with other 
buffering agents and larger sample sizes are recommended. 
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Table 2: Characteristics of Included Studies: 
Author, 
year 
No. of 
particip
ants 
Operative 
procedure 
Location 
and tooth 
type 
Anesthetic 
delivery route 
Interventions 
compared 
Definition 
of 
successful 
anesthesia 
Results 
for 
anesthetic 
success 
Al-Sultan 
et al. 2006 
 
 
 
 
80 
 
Periapical 
surgery 
Maxillary 
anterior 
teeth 
All received 
MaxBI 
I: 2% Lidocaine with 1: 
80,000 epinephrine in a 
1.7 ml solution + 0.1ml 
8.4% Sodium 
Bicarbonate, pH 7.2 (3 
carpules) 
C: 2% Lidocaine with 1: 
80,000 epinephrine in a 
1.8 ml solution, pH 3.5 
(3 carpules) 
No pain or 
mild pain 
during 
procedure 
Buffered 
LA = 
37/40 = 
92.5% 
 
Control = 
32/40 = 
80% 
Gupta et 
al. 2014 
200 Extraction Maxillary 
teeth 
All received 
MaxBI 
I: 3.7 mL 2 % lidocaine 
with 1: 80,000 
epinephrine + 1.3 mL 
7.4 % sodium 
bicarbonate, pH 7.51 
C: 3.7 mL 2 % lidocaine 
with 1: 80,000 
epinephrine, pH 3.91 
No pain or 
mild pain 
during 
procedure 
(VAS) 
Buffered 
LA = 
92/100 = 
92% 
 
Control = 
74/100 = 
74% 
Saatchi et 
al. 2015 
80 RCT for 
patients 
experienci
ng 
symptomat
ic 
irreversible 
pulpitis 
Mandibul
ar 
posterior 
teeth 
All received 
IANB 
I: 1.62 ml of 2% 
lidocaine with 1: 80,000 
epinephrine buffered 
+ 0.18 mL 8.4% sodium 
bicarbonate (2 carpules) 
C: 1.62 ml of 2% 
lidocaine with 1: 80,000 
epinephrine + 0.18 mL 
sterile distilled water (2 
carpules) 
No pain or 
mild pain 
during 
access 
cavity 
preparatio
n and 
instrument
ation (HP-
VAS) 
Buffered 
LA = 
25/40 = 
62.5% 
 
Control = 
19/40 = 
47.5% 
Saatchi et 
al. 2016 
100 RCT for 
patients 
experienci
ng 
Mandibul
ar first 
molar 
teeth 
Patients 
received buccal 
infiltration 
injection of 
I: 0.7 mL 8.4% sodium 
bicarbonate with 0.3 mL 
2% lidocaine containing 
1: 80,000 epinephrine 
No pain or 
mild pain 
during 
access 
Buffered 
LA = 
39/50 = 
78% 
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symptomat
ic 
irreversible 
pulpitis 
either 
0.7 mL 8.4% 
sodium 
bicarbonate with 
0.3 mL 2% 
lidocaine 
containing 1: 
80,000 
epinephrine or 
0.7 mL sterile 
distilled water 
with 0.3 mL 2% 
lidocaine 
containing 
1: 80,000 
epinephrine. 
After 
15 minutes, all 
the patients 
received 
conventional 
IANB injection 
using 3.6 mL 2% 
lidocaine with 
1: 80,000 
epinephrine 
or  
C: 0.7 mL sterile distilled 
water with 0.3 mL 2% 
lidocaine containing 
1: 80,000 epinephrine 
cavity 
preparatio
n and 
instrument
ation (HP-
VAS) 
Control = 
22/50 = 
44% 
Schellenb
erg et al. 
2015 
100 RCT for 
patients 
experienci
ng 
symptomat
ic 
irreversible 
pulpitis 
Mandibul
ar 
posterior 
teeth 
All received 
IANB 
I: 2.8 mL 4% lidocaine 
with 1: 100,000 
epinephrine buffered 
with 0.18 ml 8.4% 
sodium bicarbonate 
using the Onset 
buffering system, pH 
7.05 
C: 2.62 mL 4% lidocaine 
with 1: 100,000 
epinephrine, pH  4.51 
No pain or 
mild pain 
during 
procedure 
(HP-VAS) 
Buffered 
LA = 
16/50 = 
32% 
 
Control = 
20/50 = 
40% 
C: Control, I: Intervention 
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Table 3: Characteristics of Excluded Studies: 
Study Reason for exclusion 
Agarwal et al. (2015). To evaluate the anesthetic 
efficacy of sodium bicarbonate buffered 2% 
lidocaine with 1: 100,000 epinephrine in Inferior 
Alveolar Nerve Blocks: A prospective, 
randomized, double blind study 
 
Al-Sultan et al. (2004). Effectiveness of pH 
adjusted lidocaine versus commercial lidocaine 
for maxillary infiltration anesthesia 
 
Auerbach et al. (2009). A Randomized, Double-
blind Controlled study of Jet Lidocaine Compared 
to Jet Placebo for Pain Relief in Children 
Undergoing Needle Insertion in the Emergency 
Department 
 
Azizkhani et al. (2015). The effects of injections 
of warmed bicarbonate-buffered Lidocaine as a 
painkiller for patients with trauma 
 
Balasco et al. (2013). Buffered lidocaine for 
incision and drainage: A prospective, randomized 
double-blind study 
 
Bartfield et al. (1995). The effects of warming 
and buffering on pain of infiltration of lidocaine 
 
Bowles et al. (1995). Clinical evaluation of 
buffered local anesthetic 
 
Burns et al. (2006). Decreasing the pain of local 
anesthesia: a prospective, double-blind 
comparison of buffered, premixed 1% lidocaine 
with epinephrine versus 1% lidocaine freshly 
mixed with epinephrine 
Doesn’t evaluate the anesthetic success 
 
 
 
 
 
Full-text article couldn’t be retrieved 
 
 
 
Doesn’t meet inclusion criteria 
 
 
 
 
 
Patients requiring treatment other than 
dental therapy 
 
 
Didn’t define anesthetic success, didn’t 
present data as dichotomous outcome 
 
 
Patients requiring treatment other than 
dental therapy 
 
Doesn’t evaluate the anesthetic success 
 
 
Doesn’t evaluate the anesthetic success, 
Patients requiring treatment other than 
dental therapy 
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Christoph et al. (1988). Pain reduction in local 
anesthetic administration through pH buffering 
 
 
Colaric at al. (1998). Pain reduction in lidocaine 
administration through buffering and warming 
 
 
Harreld et al. (2015). Efficacy of a buffered 4% 
lidocaine formulation for incision and drainage: A 
prospective, randomized, double-blind study 
 
Hobeichet al. (2013). A prospective, randomized, 
double-blind comparison of the injection pain 
and anesthetic onset of 2% lidocaine with 1: 
100,000 epinephrine buffered with 5% and 10% 
sodium bicarbonate in maxillary infiltrations. 
 
 
Kashyap et al. (2011). Effect of alkalinisation of 
lignocaine for intraoral nerve block on pain 
during injection, and speed of onset of 
anaesthesia 
 
Kim et al. (2005). A clinical study of anesthetic 
efficacy of alkalinizing lidocaine in inferior 
alveolar nerve blocks. 
 
Lee et al. (2013). The effect of buffered lidocaine 
in local anesthesia: a prospective, randomized, 
double-blind study 
 
Malamed et al. (2013). Faster onset and more 
comfortable injection with alkalinized 2% 
lidocaine with epinephrine 1: 100,000. 
 
 
Doesn’t evaluate the anesthetic success, 
Patients requiring treatment other than 
dental therapy 
 
Doesn’t evaluate the anesthetic success, 
Patients requiring treatment other than 
dental therapy 
 
Didn’t define anesthetic success, didn’t 
present data as dichotomous outcome 
 
 
Doesn’t evaluate the anesthetic success 
 
 
 
 
 
 
Doesn’t evaluate the anesthetic success 
 
 
 
 
Healthy volunteers as subjects 
 
 
 
Patients requiring treatment other than 
dental therapy 
 
 
Doesn’t evaluate the anesthetic success 
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Matsumoto et al. (1994). Reducing the 
discomfort of lidocaine administration through 
pH buffering 
 
Momsen et al. (2000). Buffering of lignocaine-
epinephrine - A simple method for less painful 
application of local anaesthesia 
 
Primosch et al. (1996). Pain elicited during 
intraoral infiltration with buffered lidocaine 
 
Redd et al. (1990). Towards less painful local 
anesthesia 
 
Shurtz et al. (2015). Buffered 4% articaine as a 
primary buccal infiltration of the mandibular first 
molar: A prospective, randomized, double-blind 
study 
 
Singer et al. (1995). Infiltration Pain and Local 
Anesthetic Effects of Buffered vs. Plain 1% 
Diphenhydramine 
 
 
Shyamala et al. (2016). A Comparative Study 
Between Bupivacaine with Adrenaline and 
Carbonated Bupivacaine with Adrenaline for 
Surgical Removal of Impacted Mandibular Third 
Molar 
 
Whitcomb et al. (2010). A prospective, 
randomized, double-blind study of the 
anesthetic efficacy of sodium bicarbonate 
buffered 2% lidocaine with 1: 100,000 
epinephrine in inferior alveolar nerve blocks 
Doesn’t evaluate the anesthetic success, 
Patients requiring treatment other than 
dental therapy 
 
Doesn’t evaluate the anesthetic success, 
Patients requiring treatment other than 
dental therapy 
 
Doesn’t evaluate the anesthetic success 
 
 
Patients requiring treatment other than 
dental therapy 
 
Healthy volunteers as subjects 
 
 
 
 
Doesn’t evaluate the anesthetic success, 
Patients requiring treatment other than 
dental therapy 
 
 
Doesn’t evaluate the anesthetic success 
 
 
 
 
 
Healthy volunteers as subjects 
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Appendix 1: Search Strategies 
PubMed Search Strategy November 1, 2016: 
Search Query Items found Time 
#1 Search Buffers [MeSH] 21056 13:25:33 
#2 Search Sodium Bicarbonate [MeSH] 4123 13:25:45 
#3 Search Buffered 79493 13:25:54 
#4 Search Buffering 10940 13:26:03 
#5 Search Alkalinization 3544 13:26:12 
#6 Search Adjusting pH 32045 13:26:20 
#7 Search Sodium Bicarbonate 11960 13:26:32 
#8 Search ((((((Buffers [MeSH]) OR Sodium 
Bicarbonate [MeSH]) OR Buffered) OR Buffering) 
OR Alkalinization) OR Adjusting pH) OR Sodium 
Bicarbonate 
129715 13:27:17 
#9 Search Anesthetics, Local [MeSH] 30129 13:27:37 
#10 Search Local anesthetics 102586 13:27:44 
#11 Search (Anesthetics, Local [MeSH]) OR Local 
anesthetics 
102586 13:27:55 
#12 Search Dental pulp [MeSH] 10909 13:28:03 
#13 Search Injections [MeSH] 261209 13:28:10 
#14 Search Success 215780 13:28:17 
#15 Search Pain free 6366 13:28:25 
#16 Search ((((Dental pulp [MeSH]) OR Injections 
[MeSH]) OR Success) OR Pain free) 
513588 13:28:56 
#17 Search randomized controlled trial [pt] 421710 13:36:43 
#18 Search randomized [tiab] 391428 13:36:54 
#19 Search placebo [tiab] 179612 13:37:04 
#20 Search drug therapy [sh] 1876818 13:37:17 
#21 Search randomly [tiab] 260937 13:37:24 
#22 Search trial [tiab] 445253 13:37:30 
#23 Search groups [tiab] 1647429 13:37:38 
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#24 Search ((((((randomized controlled trial [pt]) OR 
randomized [tiab]) OR placebo [tiab]) OR drug 
therapy [sh]) OR randomly [tiab]) OR trial [tiab]) 
OR groups [tiab] 
3870064 13:38:14 
#25 Search ((((((((((Buffers [MeSH]) OR Sodium 
Bicarbonate [MeSH]) OR Buffered) OR Buffering) 
OR Alkalinization) OR Adjusting pH) OR Sodium 
Bicarbonate)) AND ((Anesthetics, Local [MeSH]) OR 
Local anesthetics)) AND (((((Dental pulp [MeSH]) 
OR Injections [MeSH]) OR Success) OR Pain free)) 
AND (((((((randomized controlled trial [pt]) OR 
randomized [tiab]) OR placebo [tiab]) OR drug 
therapy [sh]) OR randomly [tiab]) OR trial [tiab]) 
OR groups [tiab]) 
163 13:38:51 
#26 Search animals [mh] NOT humans [mh] 4266417 13:39:17 
#27 Search ((((((((((((Buffers [MeSH]) OR Sodium 
Bicarbonate [MeSH]) OR Buffered) OR Buffering) 
OR Alkalinization) OR Adjusting pH) OR Sodium 
Bicarbonate)) AND ((Anesthetics, Local [MeSH]) OR 
Local anesthetics)) AND (((((Dental pulp [MeSH]) 
OR Injections [MeSH]) OR Success) OR Pain free)) 
AND (((((((randomized controlled trial [pt]) OR 
randomized [tiab]) OR placebo [tiab]) OR drug 
therapy [sh]) OR randomly [tiab]) OR trial [tiab]) 
OR groups [tiab]))) NOT (animals [mh] NOT humans 
[mh]) 
154 13:52:51 
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Cochrane Central Register of Controlled Trials (CENTRAL) Search Strategy November 1, 
2016: 
Search Query Items found 
#1  "Sodium Bicarbonate":ti,ab,kw (Word variations have been 
searched)  
986 
#2 MeSH descriptor: [Sodium Bicarbonate] explode all trees  559 
#3 buffers:ti,ab,kw (Word variations have been searched)  1808 
#4  MeSH descriptor: [Buffers] explode all trees  284 
#5 buffered   842 
#6 buffering 377 
#7 alkalinization 166 
#8 adjusting PH 164 
#9 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8   3019 
#10 MeSH descriptor: [Anesthetics, Local] explode all trees   6730 
#11 MeSH descriptor: [Anesthesia, Local] explode all trees 1917 
#12 local anesthesia   9373 
#13 #10 or #11 or #12 11709 
#14 MeSH descriptor: [Dental Pulp] explode all trees  268 
#15 MeSH descriptor: [Injections] explode all trees 20305 
#16 success 18977 
#17 intraoral    677 
#18 pain free  7900 
#19 #14 or #15 or #16 or #17 or #18  50256 
#20 randomized controlled trial  552524 
#21 randomized  604020 
#22 placebo 185419 
#23 randomly 145697 
#24 trial  703496 
#25  #20 or #21 or #22 or #23 or #24 786961 
#26  #9 AND #13 AND #19 AND #25 131 
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Scopus Search Strategy November 1, 2016: 
Search Query Items found 
#1 "dental therapy"  487 
#2 dentistry  113,639 
#3 intraoral  12,050 
#4  #1 OR #2 OR #3  19,314,560 
#5 buffered   52,285 
#6 buffering 28,306 
#7 alkalinization 6,163 
#8 adjusting PH 4,592 
#9 "sodium bicarbonate" 12,543 
#10 #5 OR #6 OR #7 OR #8 OR #9 13,645,209 
#11 "Local anesthetics"  39,686 
#12 "Local anesthesia"  39,624 
#13 #11 OR #12  3,890,333 
#14 "dental pulp"   24,896 
#15 injection 1,041,097 
#16 "intraoral injection” 63 
#17  success 574,908 
#18 pain free 7,340 
#19 #14 OR #15 OR #16 OR #17 OR #18 6,767,240 
#20 “randomized controlled trial”  571,556 
#21 randomized  803,117 
#22 Placebo 341,481 
#23 “drug therapy” 495,700 
#24 randomly 425,460 
#25 trial  1,875,858 
#26 groups 6,231,839 
#27  #20 or #21 or #22 or #23 or #24 or #25 or #26 5,851,925 
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World Health Organization (WHO) International Clinical Trials Registry Platform Search 
Strategy 
Buffered AND local anesthesia 
Buffering AND local anesthesia 
Adjusting pH AND local anesthesia 
Alkalinization AND local anesthesia 
Sodium bicarbonate AND local anesthesia 
 
US National Institutes of Health Trials Registry (ClinicalTrials.gov) Search Strategy 
Buffered* AND local anesthesia* 
Buffering* AND local anesthesia* 
Adjusting pH* AND local anesthesia* 
Alkalinization* AND local anesthesia* 
Sodium bicarbonate* AND local anesthesia* 
 
OpenGrey Search Strategy 
Buffered* AND local anesthesia* 
Buffering* AND local anesthesia* 
Adjusting pH* AND local anesthesia* 
Alkalinization* AND local anesthesia* 
Sodium bicarbonate* AND local anesthesia* 
 
Google Scholar Beta Search Strategy 
Dental AND buffering AND local anesthesia AND intraoral 
 
 
 
 
 
 
#28  #4 AND # 10 AND #13 AND #19 AND #27 10,682 
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